TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biofokus
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,755
|
20,206
|
20,187 |
Financial expenses |
3
|
0
|
1 |
Earnings before taxes |
1,906
|
1,012
|
1,919 |
Total assets |
28,009
|
26,292
|
26,059 |
Current assets |
27,807
|
26,088
|
26,023 |
Current liabilities |
8,178
|
6,597
|
7,765 |
Equity capital |
19,831
|
19,695
|
18,293 |
- share capital |
49
|
53
|
51 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
70.8%
|
74.9%
|
70.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
8.8%
|
5.0%
|
9.5% |
Return on assets (ROA) |
6.8%
|
3.8%
|
7.4% |
Current ratio |
340.0%
|
395.5%
|
335.1% |
Return on equity (ROE) |
9.6%
|
5.1%
|
10.5% |
Change turnover |
2,888
|
-607
|
-819 |
Change turnover % |
15%
|
-3%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.